How to Help Your Patients Find Tranxene in Stock: A Provider's Guide

For providers who prescribe clorazepate (Tranxene), the past year has brought a familiar frustration: patients calling the office because they can't fill their prescription. While this creates significant stress for patients — particularly those on clorazepate for seizure control or long-standing anxiety — there are practical steps you and your team can take to help. This guide is designed to give prescribers and clinical staff a systematic approach to supporting patients through clorazepate access challenges in 2026.

Why Your Patients Are Struggling to Fill Clorazepate

Clorazepate is not in an official FDA shortage — but patients are facing real barriers. Very few manufacturers produce it (Recordati Rare Diseases makes the brand Tranxene; a small number of generics have historically existed), and most large chain pharmacies don't stock it as a routine item because prescribing volume is low relative to other benzodiazepines. The US clorazepate market is about $25.8 million annually — a viable but niche segment where retail stocking decisions often exclude it. A new generic from ANI Pharmaceuticals approved in early 2026 should help over time, but the immediate access challenge remains.

Step 1: Identify High-Risk Patients Before Problems Arise

Proactive identification is far more effective than reactive management. Consider flagging patients in your practice who:

Have been on clorazepate for more than 3 months (at risk for withdrawal if supply interrupted)

Use clorazepate as adjunctive anticonvulsant therapy (seizure risk with abrupt discontinuation)

Are at a pharmacy that does not typically stock Schedule IV controlled substances in lower volume

Live in rural or low-density areas with fewer pharmacy options

Step 2: Recommend medfinder to Help Patients Locate Their Prescription

One of the most effective things you can do is direct patients to medfinder.com/providers. medfinder contacts pharmacies in the patient's area on their behalf to find which ones can fill their clorazepate prescription, then texts the patient the results. This eliminates the frustrating and time-consuming process of patients calling a dozen pharmacies — and reduces the number of callbacks your office receives from patients who can't find their medication.

Step 3: Establish Relationships with Independent Pharmacies

Independent pharmacies are significantly more likely to stock or be willing to order clorazepate than large chain locations. If your practice regularly prescribes clorazepate, consider reaching out directly to local independent pharmacies to establish a referral relationship. Ask them specifically: "Do you typically carry clorazepate dipotassium? Are you willing to stock it for our patients?" Having even one or two reliable independent pharmacy contacts in your area can dramatically reduce patient access problems.

Step 4: Send Prescriptions to Multiple Pharmacies When Needed

For patients experiencing acute access difficulty, it may be clinically appropriate to send the same prescription to multiple pharmacies simultaneously (where state law permits) and let the patient fill at whichever location can dispense it first. Communicate this approach clearly to patients so they understand they should only pick up from one location. Check your state's regulations on concurrent controlled substance prescriptions to ensure compliance.

Step 5: Provide Bridge Prescriptions When There's a Gap

If a patient is running critically low and cannot locate clorazepate, consider a short bridge prescription of diazepam. Diazepam shares the primary active metabolite with clorazepate (nordiazepam/desmethyldiazepam) and represents the most pharmacologically seamless transition. A commonly referenced equivalence is clorazepate 7.5 mg ≈ diazepam 5 mg, but confirm with a pharmacist or benzodiazepine equivalency reference and adjust for the individual patient.

For epilepsy patients, use particular caution. Abrupt changes in anticonvulsant regimen are associated with seizure breakthrough, and any transition should be made as a gradual cross-titration rather than an abrupt switch.

Step 6: Counsel Patients on Refill Timing and Warning Signs

Proactively educate all clorazepate patients about the importance of refilling 7-10 days before their supply runs out. Given that the drug may need to be special-ordered by a pharmacy, waiting until the last pill is dangerous. Patients should understand that benzodiazepine withdrawal — including from clorazepate — can be medically serious and, in some cases, life-threatening.

Counsel patients to contact your office immediately — not wait for their next scheduled visit — if they cannot fill their prescription within 48 hours. Your team should have a protocol for handling these calls urgently.

Step 7: Use the Prior Authorization Process as a Lever

For patients whose insurance is denying coverage or requiring prior authorization for clorazepate, complete the PA promptly and document medical necessity clearly. Emphasize the patient's treatment history, stability on clorazepate, and the clinical risk of switching to an alternative. The fact that generic clorazepate is a cost-effective Tier 1-2 medication on most formularies typically makes PA approvals straightforward when documented properly.

Staff-Level Protocol Recommendation

Consider implementing a simple office protocol for clorazepate access calls: (1) Assess days of medication remaining; (2) Direct to medfinder for immediate pharmacy search; (3) If < 7 days remaining, escalate to clinical staff for possible bridge prescription; (4) Document all contacts in the chart. See also our article on the Tranxene shortage situation for prescribers for additional clinical context.